DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Besifloxacin
Besifloxacin
Synthesis and Biological Evaluation of Trisindolyl-Cycloalkanes and Bis- Indolyl Naphthalene Small Molecules As Potent Antibacterial and Antifungal Agents
Fluoroquinolones in Children: a Review of Current Literature and Directions for Future Research
A Study on the Efficacy and Corneal Penetration of Besifloxacin in Routine Cataract Surgery Cases
Ophthalmic Antibiotics Therapeutic Class Review (TCR)
The Grohe Method and Quinolone Antibiotics
Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus Aureus and Pseudomonas Aeruginosa Corneal Infections
Antibiotic Classes
The Identification and Characterization of Novel Antibacterial Compounds Via Target-Based and Whole Cell Screening Approaches
Ocular Toxicology and Pharmacology
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
2016 BSC Antibiotics.Pptx
Introduction and Geographic Availability of New Antibiotics Approved Between 1999 and 2014
New Perspectives on Antibacterial Drug Research
Bactericidal Activity of Besifloxacin Against Staphylococci
Antimicrobials Amy J
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Treating with Besifloxacin for Acute Bacterial Conjunctivitis: a Meta-Analysis
Antibiotics in the Clinical Pipeline in 2011
Top View
E.Johnson Supplementary
Besifloxacin, Ophthalmic
Ophthalmic Antibiotics Review 02/10/2011
Therapeutic Class Overview Ophthalmic Fluoroquinolones
Malaysian Statistics on Medicines 2015-2016
A Novel Predictive Model for the Anti-Bacterial, Anti-Malarial and Herg Cardiac QT Prolongation Properties of Fluoroquinolones Clifford Fong
Besifloxacin: a Critical Review of Its Characteristics, Properties, and Analytical Methods
Besivance Safely and 7.5 Ml Size Bottle Filled with 5 Ml of Besifloxacin Effectively
Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae
Recommendations of the SEC (Antimicrobial & Antiviral)
Besifloxacin Ophthalmic Suspension
The Use of Systemic and Topical Fluoroquinolones Abstract
The Use of Systemic and Topical Fluoroquinolones Mary Anne Jackson, MD, FAAP, Gordon E
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Besifloxacin for the Treatment of Resistant Acne Besifloxacin Zur Behandlung Von Resistenter Akne Besifloxacin Pour Traiter L’Acné Résistante
Australian Public Assessment for Besifloxacin Hydrochloride
Trends in Outpatient Prescribing Patterns for Ocular Topical Anti-Infectives in Six Major Areas of China, 2013–2019
ATC Code Title
In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone
BESIVANCE® (Besifloxacin Ophthalmic Suspension) 0.6%, for Topical Ophthalmic Use ------WARNINGS and PRECAUTIONS ------Initial U.S
Methodik Der ATC-Klassifikation Und DDD-Festlegung Für Den Deutschen